Yuhong Luo - Publications

Corrigendum to "Mechanisms of Wu Zhuyu Decoction in the treatment of hepatocellular carcinoma: An integrative review of ethnopharmacology, pharmacological actions, and clinical potential" [J. Ethnopharmacol. (2026) 121800].

Journal: Journal of ethnopharmacology

Published: May 19, 2026

Safety profile of azvudine in COVID-19 patients with renal impairment: a retrospective analysis.

Journal: Frontiers in pharmacology

Published: March 13, 2026

Mechanisms of Wu Zhuyu Decoction in the treatment of hepatocellular carcinoma: An integrative review of ethnopharmacology, pharmacological actions, and clinical potential.

Journal: Journal of ethnopharmacology

Published: February 04, 2026

Exploring Gut Microbiota in Systemic Lupus Erythematosus: Insights and Biomarker Discovery Potential.

Journal: Clinical reviews in allergy & immunology

Published: March 27, 2025

Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study.

Journal: PeerJ

Published: March 19, 2025

Role and mechanism of macrophage-mediated osteoimmune in osteonecrosis of the femoral head

Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery

Published: January 16, 2024

Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases.

Journal: Ageing research reviews

Published: December 14, 2022

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: April 28, 2022

Screening for malignant tumor cells in serous effusions with an automatic hematology analyzer using a novel diagnostic algorithm.

Journal: Annals of translational medicine

Published: December 15, 2021

TRIB3 rs6037475 is a potential biomarker for predicting felodipine drug response in Chinese patients with hypertension.

Journal: Annals of translational medicine

Published: May 13, 2020

Hepatitis B virus X protein promotes insulin-like growth factor II gene expression by inducing hypomethylation of the P3 promoter in hepatocellular carcinoma

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: September 01, 2014

Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 05, 2013